Injectable human recombinant collagen matrices limit adverse remodeling and improve cardiac function after myocardial infarction

Injectable human recombinant collagen matrices limit adverse remodeling and improve cardiac function after myocardial infarction

Many patients, following therapy for acute myocardial infarction, develop adverse cardiac remodelling. Here the authors present injectable recombinant human collagen 10 of 10 type I and III matrices that are able to limit adverse remodelling and improve function of the myocardium.

Guardado en:
Detalles Bibliográficos
Autores principales: Sarah McLaughlin, Brian McNeill, James Podrebarac, Katsuhiro Hosoyama, Veronika Sedlakova, Gregory Cron, David Smyth, Richard Seymour, Keshav Goel, Wenbin Liang, Katey J. Rayner, Marc Ruel, Erik J. Suuronen, Emilio I. Alarcon
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2019
Materias:
Science
Q
Acceso en línea:https://doaj.org/article/87f2d71678a14732bc74e04f815a25a6
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Ejemplares similares